Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Collaborator: Takeda
• Treatments: Candesartan; Candesartan cilexetil

Criteria

Inclusion Criteria:

• outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure

Exclusion Criteria:

• patients included in a clinical trial the last 30 days before consultation

• patients unable to answer the questions for linguistic or cognitive reasons

• patients who will be difficult to follow during the one year study